BioCardia
Stock Forecast, Prediction & Price Target
BioCardia Financial Estimates
BioCardia Revenue Estimates
BioCardia EBITDA Estimates
BioCardia Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.01M N/A | $1.35M 33.20% | $477K -64.71% | Avg: $700K Low: $700K High: $700K avg. 46.75% | Avg: $5.7M Low: $5.7M High: $5.7M avg. 714.28% | Avg: $56.96M Low: $56.96M High: $56.96M avg. 899.39% | Avg: $185.92M Low: $185.92M High: $185.92M avg. 226.38% |
Net Income
% change YoY
| $-12.62M N/A | $-11.91M 5.60% | $-11.57M 2.87% | Avg: $-19.1M Low: $-10.37M High: $-10.37M avg. -65.06% | Avg: $-19M Low: $-9.10M High: $-9.10M avg. 0.52% | Avg: $55.59M Low: $55.59M High: $55.59M avg. 392.61% | Avg: $29.65M Low: $29.65M High: $29.65M avg. -46.66% |
EBITDA
% change YoY
| $-12.56M N/A | $-11.90M 5.26% | $-11.56M 2.86% | Avg: $-700K Low: $-700K High: $-700K avg. 93.94% | Avg: $-5.7M Low: $-5.7M High: $-5.7M avg. -714.28% | Avg: $-56.96M Low: $-56.96M High: $-56.96M avg. -899.39% | Avg: $-185.92M Low: $-185.92M High: $-185.92M avg. -226.38% |
EPS
% change YoY
| -$0.75 N/A | -$0.67 10.66% | -$8.19 -1122.38% | Avg: -$0.49 Low: -$0.49 High: -$0.49 avg. 94.01% | Avg: -$0.43 Low: -$0.43 High: -$0.43 avg. 12.24% | Avg: $2.63 Low: $2.63 High: $2.63 avg. 710.46% | Avg: $1.4 Low: $1.4 High: $1.4 avg. -46.66% |
Operating Expenses
% change YoY
| $13.64M N/A | $13.25M -2.87% | $12.12M -8.54% | Avg: $9.19M Low: $9.19M High: $9.19M avg. -24.13% | Avg: $74.88M Low: $74.88M High: $74.88M avg. 714.28% | Avg: $748.34M Low: $748.34M High: $748.34M avg. 899.39% | Avg: $2.44B Low: $2.44B High: $2.44B avg. 226.38% |
FAQ
What is BioCardia stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 70.35% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -10.37M, average is -19.1M and high is -10.37M.
What is BioCardia stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 471.70% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $700K, average is $700K and high is $700K.
What is BioCardia stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 192.51% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.49, average is -$0.49 and high is $-0.49.